Skip to main content
. 2018 Apr 12;13:64. doi: 10.1186/s13014-018-0978-1

Fig. 2.

Fig. 2

PSA relapse-free survival for high-risk prostate cancer patients for the whole cohort (left) and the IMRT cohort only (right). The respective Cox models were used to select the patients with favorable and unfavorable outcome, respectively